The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
BSH 2022 | Lymphoma Sessions: CAR-T and lymphoma treatment in the UK
Welcome to The Lymphoma Sessions brought to you by the Video Journal of Hematological Oncology (VJHemOnc). This exclusive discussion features leading experts Robin Sanderson and Tobias Menne, who discuss lymphoma treatment in the UK, drawing focus on CAR-T therapy.
In this session, our experts will discuss recent updates in lymphoma treatment, the management of CAR-T toxicity, the ZUMA-7 and TRANSFORM trials, and how to manage the delivery of CAR-T therapy in the UK.
